Kevin Shan

Enhanced Weight Loss With Pramlintide/Metreleptin: An Integrated Neurohormonal Approach to Obesity Pharmacotherapy

Éric Ravussin, Steven R. Smith, Julie A. Mitchell et al. · Obesity · 2009 · 326 citations · Full text

Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): two randomised, double-blind, placebo-controlled, phase 3 studies

William J. Sandborn, Séverine Vermeire, Laurent Peyrin‐Biroulet et al. · The Lancet · 2023 · 304 citations · Full text

Concurrent Improvement in Both Binge Eating and Depressive Symptoms with Naltrexone/Bupropion Therapy in Overweight or Obese Subjects with Major Depressive Disorder in an Open-Label, Uncontrolled Study

Anna I. Guerdjikova, Brandon Walsh, Kevin Shan et al. · Advances in Therapy · 2017 · 50 citations · Full text

Method‐of‐use study of naltrexone sustained release (<scp>SR</scp>)/bupropion <scp>SR</scp> on body weight in individuals with obesity

Amy E. Halseth, Kevin Shan, Brandon Walsh et al. · Obesity · 2016 · 37 citations · Full text

Quality of life, binge eating and sexual function in participants treated for obesity with sustained release naltrexone/bupropion

Amy E. Halseth, Kevin Shan, Kye Gilder et al. · Obesity Science & Practice · 2018 · 30 citations · Full text